Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agatolimod Sodium + Rituximab + Y-90 Zevalin in CD20+ NHL
NCT00438880Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Oct 2004
- Primary completion
- Oct 2010
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), MicroRNA (miRNA)
- Countries
- 1
01
Overview
A Phase 2 trial of agatolimod in non-Hodgkin lymphoma (NHL), sponsored by Mayo Clinic. Started Oct 2004; status: completed.
02
Drugs
agatolimod
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00438880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00438880.